Literature DB >> 16980891

Bacterial clearance and mortality are not improved by a combination of IL-10 neutralization and IFN-gamma administration in a murine model of post-CLP immunosuppression.

E D Murphey1, Edward R Sherwood.   

Abstract

Immunocompromise after a major injury is presumed to be a predisposing factor for sepsis. Mice subjected to sublethal cecal ligation and puncture (CLP) and challenged 5 days later with Pseudomonas aeruginosa had more bacterial growth in lung tissue, lower serum interferon gamma (IFN-gamma) and interleukin (IL) 12,and higher serum IL-10 when compared with sham CLP mice challenged with Pseudomonas. To test the functional significance of these alterations in cytokine production in the immune response to bacteria, we administered IFN-gamma and anti-IL-10 to post-CLP mice before the Pseudomonas challenge. Administration of IFN-gamma and anti-IL-10 did not improve bacterial clearance or mortality in post-CLP mice. In further studies, we administered IFN-gamma to IL-10 knockout mice before a challenge with P. aeruginosa. Our results showed no significant differences in bacterial clearance or mortality in IL-10 knockout mice with or without IFN-gamma treatment compared with wild-type controls. Finally, because most mortality occurred within 2 to 3 days of the Pseudomonas challenge in the aforementioned studies and was likely associated with a marked proinflammatory response, we investigated the effect of IFN-gamma and anti-IL-10 on clearance of Pseudomonas in C3H/HeJ mice, which do not mount an exaggerated proinflammatory response to endotoxin or Gram-negative bacteria. Neither clearance of the Pseudomonas bacteria nor mortality was improved in C3H/HeJ mice receiving anti-IL-10 and IFN-gamma. These results suggest that the suppressed IFN-gamma and IL-12 responses, in combination with an exaggerated IL-10 response to P. aeruginosa challenge after injury, do not correlate with bacterial clearance or survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16980891     DOI: 10.1097/01.shk.0000226343.70904.4f

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  18 in total

1.  Cecal ligation and puncture-induced impairment of innate immune function does not occur in the absence of caspase-1.

Authors:  E D Murphey
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

2.  The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection.

Authors:  Christopher D Romero; Tushar K Varma; Jason B Hobbs; Aimee Reyes; Brandon Driver; Edward R Sherwood
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

3.  Myosin light chain kinase knockout improves gut barrier function and confers a survival advantage in polymicrobial sepsis.

Authors:  C Adam Lorentz; Zhe Liang; Mei Meng; Ching-Wen Chen; Benyam P Yoseph; Elise R Breed; Rohit Mittal; Nathan J Klingensmith; Alton B Farris; Eileen M Burd; Michael Koval; Mandy L Ford; Craig M Coopersmith
Journal:  Mol Med       Date:  2017-06-07       Impact factor: 6.354

4.  CLP-induced impairment of innate immune function is caused by exposure to the cecal lumenal contents and not the tissue trauma or tissue ischemia/necrosis components.

Authors:  E D Murphey
Journal:  Microbes Infect       Date:  2011-08-30       Impact factor: 2.700

5.  Intestine-specific overexpression of IL-10 improves survival in polymicrobial sepsis.

Authors:  Saju Rajan; Dinesh Vyas; Andrew T Clark; Cheryl A Woolsey; Jessica A Clark; Richard S Hotchkiss; Timothy G Buchman; Craig M Coopersmith
Journal:  Shock       Date:  2008-04       Impact factor: 3.454

6.  Endogenous IL-10 regulates sepsis-induced thymic apoptosis and improves survival in septic IL-10 null mice.

Authors:  S K Tschoeke; C Oberholzer; D LaFace; B Hutchins; L L Moldawer; A Oberholzer
Journal:  Scand J Immunol       Date:  2008-10-08       Impact factor: 3.487

7.  STAT3-mediated IL-17 production by postseptic T cells exacerbates viral immunopathology of the lung.

Authors:  Sumanta Mukherjee; Ronald M Allen; Nicholas W Lukacs; Steven L Kunkel; William F Carson
Journal:  Shock       Date:  2012-11       Impact factor: 3.454

Review 8.  Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.

Authors:  Guillaume Monneret; Fabienne Venet; Alexandre Pachot; Alain Lepape
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

9.  CD4-expressing cells are early mediators of the innate immune system during sepsis.

Authors:  André Martignoni; Johannes Tschöp; Holly S Goetzman; Lisa G Choi; Maria D Reid; Jay A Johannigman; Alex B Lentsch; Charles C Caldwell
Journal:  Shock       Date:  2008-05       Impact factor: 3.454

10.  Relevance of Foxp3⁺ regulatory T cells for early and late phases of murine sepsis.

Authors:  Roman Tatura; Michael Zeschnigk; Wiebke Hansen; Joerg Steinmann; Pedrina Goncalves Vidigal; Marina Hutzler; Eva Pastille; Astrid M Westendorf; Jan Buer; Jan Kehrmann
Journal:  Immunology       Date:  2015-07-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.